We are live on ! Find out more
VCYT icon

Veracyte

179 hedge funds and large institutions have $1.48B invested in Veracyte in 2019 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 55 increasing their positions, 69 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $1.64M | Put options by funds: $422K

16% more capital invested

Capital invested by funds: $1.28B → $1.48B (+$200M)

3% less first-time investments, than exits

New positions opened: 31 | Existing positions closed: 32

1.5% less ownership

Funds ownership: 109.82%108.32% (-1.5%)

4% less funds holding

Funds holding: 187179 (-8)

20% less repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 69

60% less funds holding in top 10

Funds holding in top 10: 52 (-3)

Holders
179
Holders Change
-8
Holders Change %
-4.28%
% of All Funds
3.53%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.04%
New
31
Increased
55
Reduced
69
Closed
32
Calls
$1.64M
Puts
$422K
Net Calls
+$1.22M
Net Calls Change
+$1.62M
Name Holding Trade Value Shares
Change
Change in
Stake
Calamos Advisors
101
Calamos Advisors
Illinois
$705K -$2.87M -110,750 -81%
CAM
102
ClariVest Asset Management
California
$657K -$883K -34,100 -59%
VOYA Investment Management
103
VOYA Investment Management
Georgia
$644K +$114K +4,423 +24%
BC
104
Brinker Capital
Pennsylvania
$642K +$5.54K +214 +0.9%
CEP
105
Chicago Equity Partners
Illinois
$639K -$561K -21,660 -49%
CRC
106
Curi RMB Capital
Illinois
$632K +$145K +5,600 +33%
UBS Group
107
UBS Group
Switzerland
$619K -$1.71M -66,056 -75%
MIM
108
MetLife Investment Management
New Jersey
$599K
HI
109
Handelsinvest Investeringsforvaltning
Denmark
$558K +$518K +20,000 New
FHB
110
First Hawaiian Bank
Hawaii
$525K
ProShare Advisors
111
ProShare Advisors
Maryland
$473K -$39.7K -1,533 -8%
Mirae Asset Global Investments
112
Mirae Asset Global Investments
South Korea
$471K +$170K +6,558 +64%
MLICM
113
Metropolitan Life Insurance Company (MetLife)
New York
$433K
OAM
114
Oppenheimer Asset Management
New York
$419K +$45.1K +1,743 +13%
T. Rowe Price Associates
115
T. Rowe Price Associates
Maryland
$418K -$1.87M -72,072 -83%
Legal & General Group
116
Legal & General Group
United Kingdom
$404K +$112K +4,316 +43%
ARTA
117
A.R.T. Advisors
New York
$400K +$371K +14,338 New
KC
118
Kepos Capital
New York
$390K -$76.7K -2,963 -17%
First Trust Advisors
119
First Trust Advisors
Illinois
$373K +$345K +13,346 New
Stifel Financial
120
Stifel Financial
Missouri
$369K -$1.53K -59 -0.4%
CB
121
Commerce Bank
Missouri
$366K +$339K +13,115 New
SG Americas Securities
122
SG Americas Securities
New York
$359K +$333K +12,874 New
CSS
123
Cubist Systematic Strategies
Connecticut
$354K +$328K +12,668 New
State Board of Administration of Florida Retirement System
124
State Board of Administration of Florida Retirement System
Florida
$351K +$14.2K +550 +5%
BOTOTLSJU
125
Board of Trustees of The Leland Stanford Junior University
California
$350K

VCYT Hedge Fund Activity: Q4 2019 in Review

179 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q4 2019, worth a combined $1.48B — up 16% from $1.28B a quarter earlier.

Sellers outnumbered buyers: 32 funds closed out of VCYT and 31 opened new positions — a net loss of 1 holder — while 69 trimmed existing stakes and 55 added.

The largest buyer was Artisan Partners, adding an estimated $39.2M. The largest seller was Nuveen, cutting an estimated $14.8M.

  • 179 institutional investors held Veracyte (VCYT) as of Q4 2019, down from 187 in Q3 2019.
  • Funds reported $1.48B of Veracyte stock for Q4 2019, up 16% quarter-over-quarter.
  • 31 funds opened new Veracyte positions in Q4 2019 and 32 closed out, a net change of -1 holder.
  • The largest Veracyte buyer in Q4 2019 was Artisan Partners, an estimated $39.2M added.
  • The largest Veracyte seller in Q4 2019 was Nuveen, an estimated $14.8M sold.

Based on aggregated 13F filings for Q4 2019.